Velocity 2: An Anthrax Vaccine and Antibiotics Clinical Study
Trial details
- Registry ID
- NCT04067011
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Velocity 2: An Anthrax Vaccine and Antibiotics Clinical StudyNCT04067011 | Emergent BioSolutions | Phase 2 | Completed | 2020-03-05Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |